DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS

DIRECTOR’S OFFICE

PHARMACY TECHNICIANS

Filed with the secretary of state on October 19, 2021

These rules become effective immediately upon filing with the secretary of state unless adopted

under section 33, 44, or 45a(6), of the administrative procedures act of 1969, 1969 PA 306, MCL

24.233, 24.244, or 24.245a. Rules adopted under these sections become effective 7 days after

filing with the secretary of state.

(By authority conferred on the director of the department of licensing and regulatory

affairs by sections 16145, 16148, 16184, 16201, 16204, 16205, 17731, 17739, 17739a, 17739b,

17739c, and 17742a of the public health code, 1978 PA 368, MCL 333.16145, 333.16148,

333.16184, 333.16201, 333.16204, 333.16205, 333.17731, 333.17739, 333.17739a, 333.17739b,

333.17739c, and 333.17742a, and Executive Reorganization Order Nos. 1991-9, 1996-2, 2003-1,

and 2011-4, MCL 338.3501, 445.2001, 445.2011, and 445.2030)

R 338.3651, R 338.3653, R 338.3655, R 338.3657, R 338.3659, R 338.3661, R 338.3663, and

R 338.3665 of the Michigan administrative code are amended, and R 338.3652, R 338.3654,

and R 338.3662 are added, as follows:

R 338.3651 Pharmacy technician licensure; eligibility; examination.

Rule 1. (1) An applicant for licensure by examination as a pharmacy technician shall submit a

completed application on a form provided by the department, together with the appropriate fee

unless the applicant is exempt from filing under any of the following exemptions pursuant to

section 17739a(4) of the code, MCL 333.17739a:

(a) A student enrolled in a pharmacy technician program approved by the board under R

338.3655.

(b) A licensee who holds a temporary pharmacy technician license under R 338.3652 and

section 17739b of the code, MCL 333.17739b.

(c) A licensee who holds a limited pharmacy technician licensee under section 17739c of the

code, MCL 333.17739c.

(2) In addition to meeting the requirements of section 16174 of the code, MCL 333.16174, an

applicant shall comply with all of the following requirements:

(a) Have graduated from an accredited high school or comparable school or educational

institution or passed the general educational development test or the graduate equivalency

examination.

(b) Have passed and provided proof to the department of passing any of the following

examinations:

(i) The certified pharmacy technician examination given by the Pharmacy Technician

Certification Board (PTCB) or the National Healthcareer Association (NHA).

(ii) A nationally recognized and administered pharmacy technician certification examination

that has been approved by the board under R 338.3654.

May 3, 2021

2

(iii) An employer-based training program examination that has been approved by the board

under R 338.3654.

(c) Beginning March 16, 2021, an applicant shall submit proof of having completed training in

identifying victims of human trafficking as required in R 338.3659.

R 338.3652 Temporary license.

Rule 2. (1) Subject to the limitations in section 16181 of the code, MCL 333.16181, and under

section 17739b, of the code, MCL 333.17739b, the department may issue a nonrenewable,

temporary license to an applicant who is preparing for the proficiency examination and has

completed all requirements for licensure as a pharmacy technician except passing the proficiency

examination required under section 17739a(1)(d) of the code, MCL 333.17739a.

(2) An applicant applying for a pharmacy technician temporary license shall submit a

completed application on a form provided by the department, together with the appropriate fee.

(3) The temporary license expires 1 year after the date the temporary license is issued.

R 338.3653 Licensure by endorsement.

Rule 3. (1) An applicant for licensure by endorsement shall submit a completed application on

a form provided by the department, together with the requisite fee. An applicant who meets the

requirements of this rule is presumed to meet the requirements of section 16186 of the code,

MCL 333.16186.

(2) An applicant shall satisfy all of the following requirements:

(a) Have graduated from an accredited high school or comparable school or educational

institution, or passed the general educational development test or the graduate equivalency

examination.

(b) Satisfy the requirements in section 16174 of the code, MCL 333.16174.

(c) Hold a pharmacy technician license or registration by examination in another state that is

active and in good standing.

(d) Submit proof that the applicant passed 1 of the approved examinations specified in R

338.3651(2)(b).

(e) Beginning March 16, 2021, submit proof of having completed training in identifying

victims of human trafficking as required in R 338.3659.

(3) In addition to meeting the requirements of subrules (1) and (2) of this rule, an applicant’s

license must be verified, on a form provided by the department, by the licensing agency of any

state in which the applicant holds a current license or ever held a license as a pharmacy

technician. Verification must be sent directly to the department from the licensing agency and

include the record of any disciplinary action taken or pending against the applicant.

R 338.3654 Examination requirements; board approval; approval process.

Rule 4. (1) Except for the PTCB and NHA examinations, a nationally recognized pharmacy

technician proficiency certification examination and an employer-based training program

proficiency examination must be approved by the board.

(2) An employer-based training program proficiency examination must be offered in

association with a specific employer-based training program and cover the topics specified in

section 17739a(1)(d)(iv) of the code, MCL 333.17739a.

(3) An entity that offers a nationally recognized pharmacy technician proficiency certification

examination shall submit to the department a completed application on a form provided by the

3

department with proof of current national accreditation in order to be approved by the board. If

the examination is nationally accredited, after the department processes the application, it shall

be considered approved by the board. If national accreditation is lost, the examination will no

longer be approved by the board.

(4) An entity that offers an employer-based training program proficiency examination shall

submit to the department a completed application on a form provided by the department and a

copy of the examination with the correct answers clearly identified for each question.

(5) An entity that offers an employer-based training program proficiency examination shall

submit a modification to a proficiency examination during its approval term to the department on

a form provided by the department pursuant to the requirements of this rule.

(6) Beginning July 1, 2022, a nationally recognized certification proficiency examination or

employer-based training program proficiency examination approved by the board before July 1,

2022, shall submit an application consistent with this rule for approval.

(7) Beginning July 1, 2022, the board’s approval of an examination expires 5 years after the

date of approval.

R 338.3655 Approved pharmacy technician programs.

Rule 5. (1) The following pharmacy technician programs are considered board-approved after a

completed application on a form provided by the department along with proof of accreditation is

submitted to and reviewed by the department:

(a) A pharmacy technician program including an employer-based training program that is

accredited by the American Society of Health-System Pharmacists/Accreditation Council for

Pharmacy Education Pharmacy Technician Accreditation Commission (ASHP/ACPE).

(b) A pharmacy technician program that is offered by an education program that is accredited

by the ASHP/ACPE or by an agency accredited by the United States Department of Education.

(2) If either of the following pharmacy technician programs do not meet the requirements in

subrule (1) of this rule, the program may apply for board approval by submitting an application

to the department on a form provided by the department, along with an attestation form that

verifies compliance with the information required in subrule (3) of this rule.

(a) A comprehensive curriculum-based pharmacy technician education and training program

conducted by a school that is licensed pursuant to the proprietary schools act, 1943 PA 148,

MCL 395.101 to 395.103.

(b) A pharmacy technician training program utilized by a pharmacy that includes training in

the functions, specified in section 17739(1) of the code, MCL 333.17739, and R 338.3665,

required to assist the pharmacist in the technical functions associated with the practice of

pharmacy.

(3) The contents of the training programs offered under subrule (2) of this rule must include all

of the following:

(a) The duties and responsibilities of the pharmacy technician and a pharmacist, including the

standards of patient confidentiality, and ethics governing pharmacy practice.

(b) The tasks and technical skills, policies, and procedures related to the pharmacy

technician’s position pursuant to the duties specified in section 17739(1) of the code, MCL

333.17739, and R 338.3665.

(c) The pharmaceutical-medical terminology, abbreviations, and symbols commonly used in

prescriptions and drug orders.

4

(d) The general storage, packaging, and labeling requirements of drugs, prescriptions, or drug

orders.

(e) The arithmetic calculations required for the usual dosage determinations.

(f) The essential functions related to drug, purchasing, and inventory control.

(g) The recordkeeping functions associated with prescriptions or drug orders.

(4) The pharmacy technician program shall maintain a record of a student’s pharmacy

technician training and education, specified in this rule, for 3 years after a student completes or

leaves the program, whichever is earlier, that must include all of the following:

(a) The full name and date of birth of the pharmacy technician student.

(b) The starting date of the pharmacy technician program and date the student successfully

completed the program.

(c) The program syllabus and activities performed in the program.

(5) A student shall complete a board-approved pharmacy technician program within 2 years of

beginning the program in order to maintain his or her exemption from licensure in subrule (6) of

this rule, and R 338.3651.

(6) A student in a board-approved pharmacy technician program is exempt from, and not

eligible for, licensure while in the program.

(7) Beginning July 1, 2022, a pharmacy technician program that was board approved before

July 1, 2022, must reapply and meet the requirements of this rule. Beginning July 1, 2022, the

board’s approval of a program expires 5 years after the date of approval. After 5 years, upon

review by the department, a pharmacy technician program may be reapproved if it has

maintained its accreditation.

R 338.3657 Relicensure requirements for pharmacy technicians.

Rule 7. An applicant for relicensure whose pharmacy technician license has lapsed under the

provisions of section 16201(3) or (4) of the code, MCL 333.16201, as applicable, may be

relicensed by complying with the following requirements:

(a) For a pharmacy technician who has let his or her

license lapse and who is not currently licensed in

another state:

Lapsed

0-3 years

Lapsed more

than 3 years

(i) Application and fee: Submit a completed

application on a form provided by the department,

together with the requisite fee.

(ii) Good moral character: Establish that he or she is

of good moral character as defined under sections 1

to 7 of 1974 PA 381, MCL 338.41 to 338.47.

(iii) Submit fingerprints: Submit fingerprints as

required under section 16174(3) of the code, MCL

333.16174.

√

(iv) Continuing education: Submit proof of having

completed 20 hours of continuing education specified

in R 338.3661(1)(c) that was completed within the 2-

year period preceding the date of the application for

relicensure. If the continuing education hours

submitted with the application are deficient, an

√

5

applicant shall have 2 years from the date of the

application to complete the deficient hours. The

application will be held, and the license will not be

issued until the continuing education requirements

have been met.

(v) Examination: Within 2 years of the period

preceding the application for relicensure, pass 1 of

the examinations specified in R 338.3651(2)(b)(i) to

(iii).

(vi) Beginning March 16, 2021, an applicant shall

submit proof of having completed training in

identifying victims of human trafficking as required

in R 338.3659.

(vii) Verification: Submit verification from the

licensing agency of all other states of the United

States in which the applicant has ever held a license

to practice as a pharmacy technician. Verification

must include the record of any disciplinary action

taken or pending against the applicant.

√

R 338.3659. Training standards for identifying victims of human trafficking; requirements.

Rule 9. (1) Pursuant to section 16148 of the code, MCL 333.16148, an individual licensed or

seeking licensure shall complete training in identifying victims of human trafficking that meets

the following standards:

(a) Training content covers all of the following:

(i) Understanding the types and venues of human trafficking in the United States.

(ii) Identifying victims of human trafficking in health care settings.

(iii) Identifying the warning signs of human trafficking in health care settings for adults and

minors.

(iv) Resources for reporting the suspected victims of human trafficking.

(b) Acceptable providers or methods of training include any of the following:

(i) Training offered by a nationally recognized or state-recognized health-related

organization.

(ii) Training offered by, or in conjunction with, a state or federal agency.

(iii) Training obtained in an educational program that has been approved by the board for

initial licensure, or by a college or university.

(iv) Reading an article related to the identification of victims of human trafficking that meets

the requirements of subdivision (a) of this subrule and is published in a peer review journal,

health care journal, or professional or scientific journal.

(c) Acceptable modalities of training include any of the following:

(i) Teleconference or webinar.

(ii) Online presentation.

(iii) Live presentation.

(iv) Printed or electronic media.

6

(2) The department may select and audit a sample of individuals and request documentation of

proof of completion of training. If audited by the department, an individual shall provide an

acceptable proof of completion of training, including either of the following:

(a) Proof of completion certificate issued by the training provider that includes the date,

provider name, name of training, and individual’s name.

(b) A self-certification statement by an individual. The certification statement must include

the individual’s name and either of the following:

(i) For training completed pursuant to subrule (1)(b)(i) to (iii) of this rule, the date, training

provider name, and name of training.

(ii) For training completed pursuant to subrule (1)(b)(iv) of this rule, the title of article,

author, publication name of peer review journal, health care journal, or professional or scientific

journal, and date, volume, and issue of publication, as applicable.

(3) Pursuant to section 16148 of the code, MCL 333.16148, the requirements specified in

subrule (1) of this rule apply for license renewals beginning with the first renewal cycle after

March 16, 2016, and for initial licenses issued after March 16, 2021.

R 338.3661 License renewals; continuing education requirements.

Rule 11. (1) A licensee seeking renewal of a pharmacy technician’s license, who has been

licensed for the 2-year period preceding the end of the license cycle, shall during the 2 years

immediately preceding the application for renewal, comply with all of the following:

(a) Submit to the department a completed application for renewal on a form provided by the

department together with the requisite fee.

(b) Complete the training in identifying victims of human trafficking as required in R

338.3659.

(c) Except as otherwise provided in subrule (6) of this rule, comply with 1 of the following:

(i) Complete a proficiency examination as specified in R 338.3651(2)(b)(i) to (iii).

(ii) Complete not less than 20 hours of continuing education courses or programs approved

by the board, during the 2 years preceding the application for renewal, that meet all of the

following requirements:

(A) No more than 12 hours of continuing education credit may be earned during a 24-hour

period.

(B) An applicant shall not earn credit for taking the same continuing education course or

program twice during 1 renewal period.

(C) Not less than 5 of the continuing education credits must be earned by attending live

courses, programs or activities that provide for direct interaction with instructors, peers, and

participants, including but not limited to lectures, meetings, symposia, real-time teleconferences

or webinars, and workshops.

(D) Continuing education credit must be earned as follows:

Subjects

Number of continuing

education hours required or

permitted for each activity

(I)

Pain and symptom management relating to the practice of Minimum: 1 hour

pharmacy.

(II) Patient safety.

Minimum: 1 hour

7

(III) Pharmacy law.

Minimum: 1 hour

(IV) Pharmacy-related subject matter, including the following Minimum: 17 hours in any

topics:

combination of the pharmacy-

related subject matters

included in this subparagraph.

Instruction in each subject is

not required.

Medication or drug distribution.

Inventory control systems.

Mathematics and calculations.

Biology.

Pharmaceutical sciences.

Therapeutic issues.

Pharmacy operations.

Pharmacology, drug therapy, or drug products.

Preparation of sterile products.

Prescription compounding.

Drug repackaging.

Patient interaction, or interpersonal skills, and

communication.

(2) A continuing education course or program that is offered or approved by any of the

following providers is approved by the board:

(a) A pharmacy technician educational program that has been approved by the board.

(b) A course or program approved by another state board of pharmacy.

(c) A program approved by the ASHP/ACPE.

(d) A course or program approved by the board under R 338.3663.

(3) Submission of an application for renewal shall constitute the applicant’s certification of

compliance with this rule. The licensee shall retain documentation of meeting the requirements

of this rule for a period of 4 years from the date of applying for license renewal. Failure to

comply with this rule is a violation of section 16221(h) of the code, MCL 333.16221.

(4) A request for a waiver under section 16205 of the code, MCL 333.16205, must be received

by the department before the expiration date of the license.

(5) If audited, a licensee shall submit to the department a copy of a letter or certificate of

completion that includes all of the following:

(a) The licensee’s name.

(b) The number of hours earned.

(c) The sponsor name or the name of the organization that approved the program or activity.

(d) The date on which the program was held or activity completed.

(6) Effective for applications for renewal that are filed for the renewal cycle that begins 1 year

or more after the effective date of this subrule, an applicant shall meet the requirements of this

subrule and the requirements in subrules (1)(a) and (b), (3), and (4) of this rule. An applicant for

license renewal, who has been licensed for the entire 2-year period preceding the end of the

license cycle, shall during the 2 years immediately preceding the application for renewal

complete not less than 20 hours of continuing education approved by the board under R

338.3662 as follows:

(a) An applicant for license renewal shall complete 1 hour in pharmacy ethics and

jurisprudence.

8

(b) An applicant for license renewal shall complete 1 hour in pain and symptom management

in the practice of pharmacy that includes, but is not limited to, courses in the following subjects:

(i) Behavior management.

(ii) Psychology of pain.

(iii) Pharmacology.

(iv) Behavior modification.

(v) Stress management.

(vi) Clinical applications as they relate to professional practice.

(c) An applicant for license renewal shall complete 1 hour in patient safety.

(d) An applicant for license renewal shall earn no more than 12 hours of continuing education

during a 24-hour period.

(e) An applicant for license renewal shall not earn credit for taking the same continuing

education course or program twice during 1 renewal period.

(f) An applicant for license renewal shall earn not less than 5 hours of continuing education in

live courses, programs, or activities that provide for direct interaction with instructors, peers, and

participants including, but not limited to, lectures, meetings, symposia, real-time teleconferences

or webinars, and workshops.

R 338.3662 Format of acceptable continuing education for licensees.

Rule 12. Effective for applications for renewal that are filed for the renewal cycle that begins 1

year or more after the effective date of this subrule, the board shall consider all of the following

as acceptable continuing education:

FORMAT OF ACCEPTABLE CONTINUING EDUCATION ACTIVITIES

(a) Completion of an approved continuing

education course or program related to the

The number of hours earned will

be the number of hours approved

practice of pharmacy. A continuing education by the sponsor or the approving

course or program is approved, regardless of

the format in which it is offered, if it is

organization.

approved or offered for continuing education If the activity was not approved

credit by any of the following:

for a set number of hours, then 1

credit hour for every 50 minutes of

participation may be earned.

 A pharmacy program accredited by

the ASHP/ACPE or the Canadian

Council for Accreditation of

No limitation on the number of

hours earned.

Pharmacy Programs (CCAPP).

 A continuing education sponsoring

organization, institution, or individual

approved by the ASHP/ACPE.

 Another state board of pharmacy.

If audited, a licensee shall submit to the

department a copy of a letter or certificate of

completion showing the licensee’s name,

number of hours earned, sponsor name or the

name of the organization that approved the

program or activity for continuing education

9

credit, and the date on which the program was

held, or activity completed.

(b) Completion of pharmacy practice or

administration courses offered for credit in a

pharmacy program accredited by the

ASHP/ACPE or the CCAPP.

Twelve hours of continuing

education will be credited for each

academic quarter credit earned and

18 hours will be credited for each

academic semester credit earned.

If audited, a licensee shall submit to the

department an official transcript that reflects

completion of the postgraduate pharmacy

practice or administration course and number

of semester or quarter credit hours earned.

No limitation on the number of

hours earned.

(c) Participation in a home study program offered One hour will be earned for each

through an ASHP/ACPE-approved provider hour devoted to a home study

or other instructional approaches that include program.

an evaluation component including, but not

limited to, on-line continuing education

programs and journal articles.

A maximum of 20 hours per

renewal period.

If audited, a licensee shall submit to the

department an affidavit attesting to the

number of hours the licensee spent

participating in the home study program that

includes a description of the activity.

(d) Renewal of a pharmacy technician license

held in another state that requires continuing

education for license renewal that is

Twenty hours will be earned.

A maximum of 20 hours may be

substantially equivalent in subject matter and earned in each renewal period.

total amount of required hours to that

required in these rules if the licensee resides

and practices in another state.

If audited, a licensee shall submit to the

department proof of current licensure in

another state and a copy of a letter or

certificate of completion showing all of the

following: the licensee’s name, number of

hours earned, the sponsor’s name or the name

of the organization that approved the program

or activity for continuing education credit,

and the date on which the program was held

or the activity was completed.

(e) Initial publication of an article or a chapter

related to the practice of pharmacy in either

of the following:

Ten hours will be earned per

publication.

A maximum of 10 hours may be

 A pharmacy textbook.

10

earned in each renewal period.

 A peer reviewed journal.

If audited, a licensee shall submit to the

department a copy of the publication that

identifies the licensee as the author or a

publication acceptance letter.

(f) Presentation of a continuing education

program approved by the board under R

Two hours will be earned for

every 50 minutes devoted to

338.3663 or subdivision (a) of this rule that is presenting the program.

not a part of the licensee’s regular job

description.

A maximum of 10 hours may be

earned in each renewal period.

If audited, a licensee shall submit to the

department a copy of the curriculum and a

letter from the program sponsor verifying the

length and date of the presentation.

(g) Attendance at a pharmacy-related program,

that is approved by the board pursuant to R

338.3663.

The number of hours earned will

be the number of hours approved

by the sponsor or the approving

organization.

If audited, a licensee shall submit to the

department a copy of a letter or certificate of

completion showing the licensee’s name,

If the activity was not approved

for a set number of hours, then 1

number of hours earned, sponsor name or the credit hour for every 50 minutes of

name of the organization that approved the

program or course for continuing education

participation may be earned.

credit, and the date on which the program was No limitation on the number of

held or the activity was completed.

hours earned.

R 338.3663 Continuing education standards for approval.

Rule 13. (1) A continuing education course or program that is not pre-approved under R

338.3661(2) or 338.3662(a) may be approved by the board by the course or program sponsor

submitting to the department a completed application on a form provided by the department, no

later than 70 days before the course or program date, and no later than 70 days before the next

regularly scheduled board meeting. A course or program conducted before board consideration

and approval shall be denied approval. The application and supporting documentation must

include all of the following information:

(a) A course or program schedule that includes all of the following:

(i) The date of the course or program.

(ii) The topics to be covered in the course or program.

(iii) The names of all of the speakers.

(iv) Break times.

(b) An explanation of how the course or program is designed to further educate pharmacy

technicians, including a short narrative describing the program content and the criteria for the

selection of this topic.

(c) Copies of instructional objectives that have been developed.

11

(d) Copies of all promotional and advertising materials for the course or program.

(e) The name, title, and address of the course or program director and a description of his or

her qualifications to direct the course or program.

(f) A description of how the amount of continuing education credit to be awarded for this

course or program was determined.

(g) A description of how participants will be notified that continuing education credit has been

earned.

(h) A description of the physical facilities, lab, or pharmacy available to ensure a proper

learning environment.

(i) A copy of the curriculum vitae for each instructional staff member.

(j) A description of the delivery method to be used and the techniques that will be employed to

assure active participation.

(k) A copy of the post-test instrument that will be used for participant evaluation.

(l) A description of how post tests will be administered, corrected, and returned to participants.

(m) A description of how post-test performance will influence the awarding of continuing

education credit.

(n) A description of how attendance will be monitored, including sample documents, and the

name of the person monitoring attendance.

(2) A course or program must meet the standards and criteria for an acceptable category of

continuing education in effect at the time of application and must be relevant to health care and

advancement of the licensee’s pharmacy technician education.

(3) The continuing education course or program approved under subrule (1) of this rule must

meet all of the following:

(a) Be an organized course or program of learning that contributes to the advancement and

enhancement of professional competency and scientific knowledge in the practice of pharmacy

and be designed to reflect the educational needs of pharmacy technicians.

(b) Have a scientific and educational integrity and contain generally accepted pharmacy

practices.

(c) Have an outline that demonstrates consistency with the course or program description and

reflects the course or program content.

(d) Be taught in a manner appropriate to the educational content, objectives, and purpose of

the course or program and allow suitable time to be effectively presented to the audience.

(e) Provide instructors who have the necessary qualifications, training, and experience to teach

the course or program.

(f) Provide for active participation and involvement from the participants.

(g) Offer educational materials for each continuing education activity that enhances the

participant’s understanding of the content and foster applications to pharmacy practice.

(h) Include learning assessments in each activity that allow pharmacy technicians to assess

their achievement of the learned content. Completion of a learning assessment is required for

continuing education content.

(4) Board approval is valid for a 3-year term from the date of the board’s approval.

(5) The board shall reevaluate a course or program before any changes are made during the

approval term, including but not limited to, changes to either of the following:

(a) Instructors and speakers.

(b) Course or program content, title, and number of continuing education hours to be awarded

to participants.

12

(6) All of the following apply regarding changes to a previously approved course or program:

(a) Subject to subdivision (b) of this rule, all changes to a previously approved course or

program must be submitted on required department forms at least 70 days before the date the

course or program is offered to participants and at least 70 days before the next regularly

scheduled board meeting to be considered for approval by the board. Any changes to a submitted

and previously approved course or program, other than those approved under subdivision (b) of

this subrule, must not be made to the course or program without prior approval.

(b) Emergency changes to instructors and speakers that cannot be submitted to the board at

least 70 days before the date of the course or program or at least 70 days before the next

regularly scheduled board meeting may be reviewed by the department in consultation with the

board chair or a continuing education board committee member if proof that is acceptable to the

department and that supports the nature of the emergency is submitted with the change.

(c) The specific dates that the course or program will be offered do not require further board

approval and may be changed without review by the board if the presentation dates are within the

board’s original 3-year term of approval.

(7) The provider or sponsor of a course or program shall issue certificates or letters of

attendance that include all of the following:

(a) The name of the sponsor.

(b) The name of the course or program.

(c) The name of the attendee.

(d) The date of the course or program.

(e) The continuing education approval number assigned by the department and current

approval term.

(f) The signature of the person responsible for attendance monitoring and his or her title.

(g) The number and type of hours awarded.

(8) The provider or sponsor of a course or program shall maintain records of the information

contained in subrule (7) of this rule for 5 years after the course or program is offered to

participants.

(9) The board may revoke the approval status of any approved course or program at any time

the course or program fails to comply with these rules.

R 338.3665 Performance of activities and functions; delegation.

Rule 15. In addition to performing the functions described in section 17739(1) of the code,

MCL 333.17739, a licensed pharmacy technician may also engage in the following tasks, under

the delegation and supervision of a licensed pharmacist:

(a) Reconstituting non-sterile dosage forms consistent with approved labeling provided by the

manufacturer of a commercially available product.

(b) Technology-assisted final product verification, which includes all the following:

(i) A second licensed pharmacy technician verifies the work of the first licensed pharmacy

technician to perform final product verification.

(ii) The first-licensed pharmacy technician processes a medication order or prescription.

(iii) The first-licensed pharmacy technician processes the medication order or prescription

using bar coding or another board-approved error prevention technology.

(iv) A pharmacist verifies the first-licensed pharmacy technician’s processing of the

medication order or prescription.

13

(v) The second licensed pharmacy technician technology-assisted final product verification is

subject to all of the following requirements:

(A) The licensed pharmacy technician holds a current full pharmacy technician license in this

state, not a temporary or limited license.

(B) The licensed pharmacy technician performing technology-assisted final product

verification has completed a board approved pharmacy technician program under R 338.3655.

(C) The licensed pharmacy technician performing technology-assisted final product

verification has not less than 1,000 hours of pharmacy technician work experience in the same

kind of pharmacy practice site in which the technology-assisted final product verification is

performed while he or she holds a current full pharmacy technician license in this state, not a

temporary or limited license.

(D) The practice setting where a licensed pharmacy technician performs technology-assisted

final product verification has in place policies and procedures including a quality assurance plan

governing pharmacy technician technology-assisted final product verification.

(E) The licensed pharmacy technician uses a technology-enabled verification system to

perform final product verification.

(F) The technology enabled verification system must document and electronically record

each step of the prescription process including which individuals complete each step.

(G) A licensed pharmacy technician shall not perform technology-assisted final product

verification for sterile or nonsterile compounding.

(H) Technology-assisted final product verification by a licensed pharmacy technician is not

limited to a practice setting.

(I) Except for a remote pharmacy that is regulated under sections 17742a and 17742b of the

code, MCL 333.17742a and MCL 333.17742b, a pharmacy technician shall not participate in

technology-assisted final product verification remotely. Technology-assisted product verification

must be done on-site.

(J) A pharmacist using his or her professional judgment may choose to delegate technology-

assisted final product verification after ensuring licensed pharmacy technicians have completed

and documented relevant training and education.